Opicapone

奥吡卡朋

Report date: 2024/11/14 09:43:54
NME

Base Information

Drug NameOpicapone
Drug Alias Name奥匹卡朋opicaponeopicaponumopicaponaOngentys +[8] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCatechol-O-methyl transferase inhibitors
TargetsCatechol-O-methyl transferase
Therapy Area/IndicationsEpilepsyParkinson DiseaseParkinsonian Disorders
Global Approved IndicationsParkinson DiseaseParkinsonian Disorders
Approved Indications in ChinaN/A
Original Approved Country/TerritoryEU
Original Approved Date2016/06/24
Country/TerritoryMainland China(BOAO LECHENG)BulgariaCanada +[17] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaNDA/BLA
Originator CompaniesBial-Portela
China Registration ClassN/A

Develop Information

Active CompaniesBial - Portela C SaAmnealBIAL-Portela & CA SA +[4] 
Inactive CompaniesAmerican Friends Of Rabin Medical Center IncShanghai Fosun Pharmaceutical Industrial Development Co Ltd
Active IndicationsParkinson DiseaseParkinsonian Disorders
Inactive IndicationsEpilepsy

Other Information

ATC CodeN04BX04
Related LinksWikipediaDrugBankKEGG